Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45


The Effectiveness of Mindfulness-Based Interventions on Maternal Perinatal Mental Health Outcomes: a Systematic Review.

Shi Z, MacBeth A.

Mindfulness (N Y). 2017;8(4):823-847. doi: 10.1007/s12671-016-0673-y. Epub 2017 Jan 19. Review.


Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation.

Cantarutti A, Merlino L, Monzani E, Giaquinto C, Corrao G.

PLoS One. 2016 Dec 15;11(12):e0168115. doi: 10.1371/journal.pone.0168115. eCollection 2016.


Selective Serotonin Reuptake Inhibitor Use during Pregnancy and the Risk of Autism Spectrum Disorders: A Review.

Boukhris T, Bérard A.

J Pediatr Genet. 2015 Jun;4(2):84-93. doi: 10.1055/s-0035-1556744. Review.


Effects of Fluoxetine on Human Embryo Development.

Kaihola H, Yaldir FG, Hreinsson J, Hörnaeus K, Bergquist J, Olivier JD, Åkerud H, Sundström-Poromaa I.

Front Cell Neurosci. 2016 Jun 16;10:160. doi: 10.3389/fncel.2016.00160. eCollection 2016.


Perinatal Health of Women with Intellectual and Developmental Disabilities and Comorbid Mental Illness.

Brown HK, Cobigo V, Lunsky Y, Dennis CL, Vigod S.

Can J Psychiatry. 2016 Nov;61(11):714-723. Epub 2016 May 5.


Selective serotonin reuptake inhibitor discontinuation during pregnancy: at what risk?

Ejaz R, Leibson T, Koren G.

Can Fam Physician. 2014 Dec;60(12):1105-6. No abstract available.


Preconception care: screening and management of chronic disease and promoting psychological health.

Lassi ZS, Imam AM, Dean SV, Bhutta ZA.

Reprod Health. 2014 Sep 26;11 Suppl 3:S5. doi: 10.1186/1742-4755-11-S3-S5. Epub 2014 Sep 26. Review.


Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.

Forsberg L, Navér L, Gustafsson LL, Wide K.

PLoS One. 2014 Nov 3;9(11):e111327. doi: 10.1371/journal.pone.0111327. eCollection 2014.


Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges.

Epstein RA, Moore KM, Bobo WV.

Drug Healthc Patient Saf. 2014 Sep 18;6:109-29. doi: 10.2147/DHPS.S43308. eCollection 2014. Review.


Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.

Hanley GE, Mintzes B.

BMC Pregnancy Childbirth. 2014 Jul 22;14:242. doi: 10.1186/1471-2393-14-242.


Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.

Huybrechts KF, Sanghani RS, Avorn J, Urato AC.

PLoS One. 2014 Mar 26;9(3):e92778. doi: 10.1371/journal.pone.0092778. eCollection 2014. Review.


Prenatal antidepressant exposure: clinical and preclinical findings.

Bourke CH, Stowe ZN, Owens MJ.

Pharmacol Rev. 2014 Feb 24;66(2):435-65. doi: 10.1124/pr.111.005207. Print 2014. Review.


Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.

Engelstad HJ, Roghair RD, Calarge CA, Colaizy TT, Stuart S, Haskell SE.

Neonatology. 2014;105(2):149-54. doi: 10.1159/000356774. Epub 2013 Dec 18.


Antidepressant use in pregnant and postpartum women.

Yonkers KA, Blackwell KA, Glover J, Forray A.

Annu Rev Clin Psychol. 2014;10:369-92. doi: 10.1146/annurev-clinpsy-032813-153626. Epub 2013 Dec 2. Review.


The use of central nervous system active drugs during pregnancy.

Källén B, Borg N, Reis M.

Pharmaceuticals (Basel). 2013 Oct 10;6(10):1221-86. doi: 10.3390/ph6101221.


A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.

Huang H, Coleman S, Bridge JA, Yonkers K, Katon W.

Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):13-8. doi: 10.1016/j.genhosppsych.2013.08.002. Epub 2013 Oct 2.


The use of psychotropic medication during pregnancy: how about the newborn?

Kieviet N, Dolman KM, Honig A.

Neuropsychiatr Dis Treat. 2013;9:1257-66. doi: 10.2147/NDT.S36394. Epub 2013 Aug 28. Review.


The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring.

Olivier JD, Akerud H, Kaihola H, Pawluski JL, Skalkidou A, Högberg U, Sundström-Poromaa I.

Front Cell Neurosci. 2013 May 21;7:73. doi: 10.3389/fncel.2013.00073. eCollection 2013.


Placental serotonin: implications for the developmental effects of SSRIs and maternal depression.

Velasquez JC, Goeden N, Bonnin A.

Front Cell Neurosci. 2013 Apr 23;7:47. doi: 10.3389/fncel.2013.00047. eCollection 2013.


Does fetal exposure to SSRIs or maternal depression impact infant growth?

Wisner KL, Bogen DL, Sit D, McShea M, Hughes C, Rizzo D, Confer A, Luther J, Eng H, Wisniewski SW.

Am J Psychiatry. 2013 May;170(5):485-93. doi: 10.1176/appi.ajp.2012.11121873. Erratum in: Am J Psychiatry. 2013 Oct 1;70(10):1218.

Supplemental Content

Support Center